Taysha Gene Therapies Inc (TSHA)
2.57
-0.01
(-0.39%)
USD |
NASDAQ |
May 03, 16:00
2.575
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -2.47K% |
June 30, 2023 | -1.03K% |
Date | Value |
---|---|
March 31, 2023 | -374.5% |
December 31, 2022 | -2.20K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.47K%
Minimum
Sep 2023
-374.5%
Maximum
Mar 2023
-1.52K%
Average
-1.61K%
Median
Profit Margin (Quarterly) Benchmarks
Aquestive Therapeutics Inc | -61.42% |
Lifecore Biomedical Inc | -- |
Relmada Therapeutics Inc | -- |
ACADIA Pharmaceuticals Inc | 19.82% |
Cyclacel Pharmaceuticals Inc | -17.00K% |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -82.29% |
Return on Invested Capital | -331.6% |
Operating Margin (Quarterly) | -438.3% |
Return on Net Operating Assets | -236.1% |